跳至主要内容
临床试验/NCT06030817
NCT06030817招募中不适用

A Prospective Study to Explore the Performance and Efficacy of 99mTc-CNDG Injection in Malignant Tumors

Peking Union Medical College Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年8月11日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
Compared with 18F-FDG PET/CT or CECT

研究概览

简要总结

Currently, 18F-fluorodeoxyglucose (18F-FDG) is the most widely used tumor imaging agent in clinical practice. However, the production of 18F requires accelerators and is associated with relatively high diagnostic costs, which to some extent limits its widespread clinical application. In comparison to Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT) devices are more abundant and offer lower diagnostic expenses. With the utilization of Cadmium Zinc Telluride (CZT) crystals in SPECT and advancements in image reconstruction techniques, the resolution and sensitivity of SPECT is continually improving. Therefore, the development of a simplified and cost-effective novel SPECT tumor imaging agent holds significant practical significance. This study involved the design and synthesis of a glucose-derived ligand with a linker containing seven methylene units and an isonitrile group (CN7DG). The CN7DG ligand was labeled with 99mTc to prepare a more lipophilic 99mTc-CN7DG complex, aiming to investigate a novel SPECT imaging agent for tumor imaging.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18-70 years old
  • Patients diagnosed with malignant glioma, colorectal cancer, pancreatic cancer, lung cancer, breast cancer, or other malignant tumors through imaging techniques such as MRI, CT, and ultrasound, and who are scheduled for surgical resection or biopsy
  • Solid tumor sizes greater than 2cm
  • Voluntarily agree to participate and sign an informed consent form
  • Can provide complete surgical records, pathological results, control data, and clinical follow-up results

排除标准

  • Pre-treatment such as chemotherapy and targeted therapy has been administered
  • Pregnancy and breastfeeding
  • Claustrophobia
  • The condition is severe and difficult to cooperate with
  • Unable to obtain relevant control imaging data and clinical information

结局指标

主要结局

Compared with 18F-FDG PET/CT or CECT

时间窗: through study completion, an average of 1 year

The number of lesions detected by 99mTc-CNDG SPECT/CT was compared with 18F-FDG PET/CT or CECT

Lesions detected by 99mTc-CNDG SPECT/CT

时间窗: through study completion, an average of 1 year

The number of target lesions was calculated by 99mTc-CNDG SPECT/CT

Uptake value of 99mTc-CNDG in malignant tumors

时间窗: through study completion, an average of 1 year

The uptake value was measured in the malignant lesions on 99mTc-CNDG SPECT/CT.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

99mTc-CNDG Injection in the Diagnosis of Malignant... | 临床试验